Amneal Pharmaceuticals, Inc. (AMRX)
Nasdaq: AMRX · CIK 0001723128 · United States
Every official Amneal Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open AMRX filings
Amneal Pharmaceuticals, Inc. documents
- Amneal Pharmaceuticals, Inc. 10-K 2026AMRX 10-K 2026: annual report for fiscal 2026
- Amneal Pharmaceuticals, Inc. 10-K 2025AMRX 10-K 2025: annual report for fiscal 2025
- Amneal Pharmaceuticals, Inc. 10-K 2024AMRX 10-K 2024: annual report for fiscal 2024
- Amneal Pharmaceuticals, Inc. 10-K 2023AMRX 10-K 2023: annual report for fiscal 2023
- Amneal Pharmaceuticals, Inc. 10-K 2022AMRX 10-K 2022: annual report for fiscal 2022
- Amneal Pharmaceuticals, Inc. 10-Q 2026AMRX 10-Q 2026: quarterly report for fiscal 2026
- Amneal Pharmaceuticals, Inc. 10-Q 2025AMRX 10-Q 2025: quarterly report for fiscal 2025
- Amneal Pharmaceuticals, Inc. 10-Q 2024AMRX 10-Q 2024: quarterly report for fiscal 2024
- Amneal Pharmaceuticals, Inc. 10-Q 2023AMRX 10-Q 2023: quarterly report for fiscal 2023
- Amneal Pharmaceuticals, Inc. 10-Q 2022AMRX 10-Q 2022: quarterly report for fiscal 2022
- Amneal Pharmaceuticals, Inc. 8-K 2026AMRX 8-K 2026: current report for fiscal 2026
- Amneal Pharmaceuticals, Inc. 8-K 2025AMRX 8-K 2025: current report for fiscal 2025
- Amneal Pharmaceuticals, Inc. 8-K 2024AMRX 8-K 2024: current report for fiscal 2024
- Amneal Pharmaceuticals, Inc. 8-K 2023AMRX 8-K 2023: current report for fiscal 2023
- Amneal Pharmaceuticals, Inc. 8-K 2022AMRX 8-K 2022: current report for fiscal 2022
- Amneal Pharmaceuticals, Inc. DEF 14A 2026AMRX DEF 14A 2026: proxy statement for fiscal 2026
- Amneal Pharmaceuticals, Inc. DEF 14A 2025AMRX DEF 14A 2025: proxy statement for fiscal 2025
- Amneal Pharmaceuticals, Inc. DEF 14A 2024AMRX DEF 14A 2024: proxy statement for fiscal 2024
- Amneal Pharmaceuticals, Inc. DEF 14A 2023AMRX DEF 14A 2023: proxy statement for fiscal 2023
- Amneal Pharmaceuticals, Inc. DEF 14A 2022AMRX DEF 14A 2022: proxy statement for fiscal 2022
- Amneal Pharmaceuticals, Inc. Form 4 2026AMRX Form 4 2026: insider trading filing for fiscal 2026
- Amneal Pharmaceuticals, Inc. Form 4 2025AMRX Form 4 2025: insider trading filing for fiscal 2025
- Amneal Pharmaceuticals, Inc. Form 4 2024AMRX Form 4 2024: insider trading filing for fiscal 2024
- Amneal Pharmaceuticals, Inc. Form 4 2023AMRX Form 4 2023: insider trading filing for fiscal 2023
- Amneal Pharmaceuticals, Inc. Form 4 2022AMRX Form 4 2022: insider trading filing for fiscal 2022
- Amneal Pharmaceuticals, Inc. S-1 2026AMRX S-1 2026: registration statement for fiscal 2026
- Amneal Pharmaceuticals, Inc. S-1 2025AMRX S-1 2025: registration statement for fiscal 2025
- Amneal Pharmaceuticals, Inc. S-1 2024AMRX S-1 2024: registration statement for fiscal 2024
- Amneal Pharmaceuticals, Inc. S-1 2023AMRX S-1 2023: registration statement for fiscal 2023
- Amneal Pharmaceuticals, Inc. S-1 2022AMRX S-1 2022: registration statement for fiscal 2022
- Amneal Pharmaceuticals, Inc. 13F 2026AMRX 13F 2026: institutional holdings for fiscal 2026
- Amneal Pharmaceuticals, Inc. 13F 2025AMRX 13F 2025: institutional holdings for fiscal 2025
- Amneal Pharmaceuticals, Inc. 13F 2024AMRX 13F 2024: institutional holdings for fiscal 2024
- Amneal Pharmaceuticals, Inc. 13F 2023AMRX 13F 2023: institutional holdings for fiscal 2023
- Amneal Pharmaceuticals, Inc. 13F 2022AMRX 13F 2022: institutional holdings for fiscal 2022
More companies